AAAAI logo

Home

 Allergy & Asthma Disease Management Center
Funded by an educational grant from sanofi-aventis US


Ask the Expert Current Literature Quiz of the Month Allergy/Respiratory Digest CME Article Meetings/Calendars AAAAI Educational Resources Other Links Comments/Suggestions



July 2005 QUIZ OF THE MONTH . . .

Inhaled long acting beta agonists (LABA) such as salmeterol (Sal) or formoterol (Form) are now being used frequently in the treatment of persistent asthma (PA). Which of the statements about LABA are true or false?

  1. Use of LABA along with inhaled corticosteroids (ICS) allows a significant reduction in the dose of ICS required to control moderate PA.

  2. Salmeterol can be used effectively as rescue treatment of acute asthma episodes as well as long-term controller treatment.

  3. Formoterol can be used effectively as rescue treatment of acute asthma episodes as well as long-term controller treatment

  4. Expiratory airflow rates are gradually reduced during chronic treatment with LABA.

  5. The bronchodilator effect of inhaled albuterol (a short acting beta agonist) is frequently reduced in asthmatics treated chronically with LABA.


Think you have the answers?

Click here to find out if you're right!

<== Back



Please tell us what you think of this site.